The News Review:
- utsourcing of Drug Trials Is Faulted
- AVI BioPharma Announces Treatment of First Patient in Systemic …
- USF dean in bike case to resign
- Cystic Fibrosis Foundation Therapeutics Implements Medidata Rave …
- MCRC Paves Path to Expanded Phase I Clinical Studies
- Covance Adds Clinical peration Director to Periapproval Services
utsourcing of Drug Trials Is Faulted
New York Times United States -
The authors suggest that human volunteers in foreign countries may be unduly influenced with the promise of financial compensation or free medical care to participate in clinical trials. The report “Ethical and Scientific Implications of the Globalization of Clinical Research” also asks whether drug research conducted in developing countries is relevant to the treatment of American patients. “We don’t want to imagine that lower-income countries are the clinical trial mill for higher-income countries” Dr. Schulman the lead author of the article said in a phone interview last week.
AVI BioPharma Announces Treatment of First Patient in Systemic …
CNNMoney.com -
DMD is an incurable muscle-wasting disease associated with errors in thegene that codes for dystrophin a protein that plays a key structural rolein muscle fiber function. AVI-4658 is designed to skip exon 51 of thedystrophin gene allowing for restoration of the reading frame in the mRNAsequence. Based on its pre-clinical research and the Phase 1 trialresults AVI believes that by skipping this exon a truncated butfunctional form of the dystrophin protein is produced to ameliorate thedisease process potentially prolonging and improving the quality of lifein these patients. About Duchenne Muscular Dystrophy (DMD)DMD is one of the most common fatal genetic disorders to affect childrenaround the world. Approximately one in every 3500 boys worldwide isafflicted with Duchenne muscular dystrophy with 20000 new cases reportedeach year. It is a devastating and incurable muscle-wasting diseaseassociated with specific inborn errors in the gene that codes fordystrophin a protein that plays a key structural role in muscle fiberfunction. Symptoms usually appear in male children before age 6.
USF dean in bike case to resign
Tampabay.com FL -
“Rao’s titles include professor of surgery and molecular medicine senior associate vice president for USF Health senior associate vice president for research and medical director of clinical research for Tampa General Hospital. Hoad said Rao’s decision to resign indicates he will be vacating all of those positions. His duties have already been temporarily divided up among other administrators according to a memo from Klasko:• Patricia Emmanuel associate dean for clinical research will be responsible for the office of clinical research and will be medical director of clinical research at TGH. • Phil Marty associate vice president for strategic partnerships and government affairs will supervise the College of Medicine. • Karen Holbrook vice president for research and innovation becomes responsible for research integrity compliance and comparative medicine. • Michael Barber associate dean for graduate and postdoctoral affairs is responsible for all graduate and postdoctoral issues at the College of Medicine. Given the financial climate USF has no immediate plans to conduct a search to replace Rao Hoad said.
Cystic Fibrosis Foundation Therapeutics Implements Medidata Rave …
MarketWatch (press release) -
Evans Manager of Biostatistics and Clinical Data Management at the CFFT TDN Coordinating Center. “Because it will enable our research sponsors to access and manage trial data more efficiently and reduce costs Medidata Rave will be critical to the success of our upcoming cystic fibrosis research. With the implementation of Medidata Rave the Coordinating Center expects to offer a more cost-effective solution to conducting clinical research. Standardized and reusable electronic case report forms (eCRFs) and edit checks across multiple studies will increase efficiency and generate significant cost savings by allowing the CFFT TDN to conduct more studies using the same resources. Implementing Medidata Rave will also decrease time dedicated to study startup data cleaning and study closeout. Additionally with Medidata Rave’s online monitoring capabilities trial managers and monitors will have instantaneous access to research data. “ver the years the CFFT TDN and Seattle Children’s Research Institute have achieved significant clinical breakthroughs and we are proud that Medidata Rave has been selected as the EDC and CDM solution that will help facilitate these cystic fibrosis studies” said Tarek Sherif CE of Medidata Solutions.
MCRC Paves Path to Expanded Phase I Clinical Studies
PharmaLive.com (press release) PA -
It can be accomplished when you have 10 physicians and two nurse practitioners. Last year we generated over 30000 patient visits. "Located on the campus of UT Southwestern at St. Paul University Hospital MCRC is a multi-specialty clinical research site headed by rheumatologists Dr. Fleischmann and Dr.
Covance Adds Clinical peration Director to Periapproval Services
PharmaLive.com (press release) PA -
With more than 18 years of clinical research and clinical trial management experience Ms. DiGiambattista previously supported projects for major pharmaceutical companies as a therapeutic area regional associate director. These projects involved various therapeutic areas including internal medicine diabetes cardiovascular CNS psychiatry and neurology. DiGiambatttista holds a bachelor’s degree in Public Health Education from West Chester University and a master’s degree in Health Administration of Gerontology Services from St.
Related from Guanxithebook: New Fallout 3 DLC hits Xbox Live Marketplace.
